Insider buying on Feb 13, 2026
53 open-market insider purchases filed with the SEC on Feb 13, 2026, worth $72.42M in total. Largest: NFRX ($40M).
← Feb 12, 2026 · Feb 17, 2026 →
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13 | NFRX2023 ETF Series Trust | Harrison Street Real Assets F…10% Owner | $40M | 1,485,332 | $26.93 | -0.7% | +64% | Feb 12 | SEC |
| Feb 13 | NDAQNasdaq, Inc. | Investor Abindirect10% Owner | $15.84M | 200,000 | $79.18 | +39% | +0% | Feb 13 | SEC |
| Feb 13 | WRBBerkley W R Corp | MS&AD Insurance Group Holding…10b5-110% Owner | $2.84M | 40,000 | $70.93 | +8.1% | +0% | Feb 12 | SEC |
| Feb 13 | PSECProspect Capital Corp | Eliasek M GrierChief Operating Officer, Director | $2.75M | 942,800 | $2.92 | -51% | +38% | Feb 11 | SEC |
| Feb 13 | PSNLPersonalis, Inc. | Tempus AI, Inc.10% Owner | $2.74M | 320,267 | $8.55 | +85% | +2% | Nov 18 | SEC |
| Feb 13 | AREAlexandria Real Estate Equiti… | Marcus Joel SExecutive Chairman, Director | $1.35M | 25,000 | $53.92 | -15% | +5% | Feb 12 | SEC |
| Feb 13 | NPBNorthpointe Bancshares Inc | Williams Charles Alan +1Chairman & CEO, Director, 10% Own… | $635.90K | 37,655 | $16.89 | -4.4% | — | Feb 11 | SEC |
| Feb 13 | ZBIOZenas BioPharma, Inc. | Lu HongboindirectDirector | $584.66K | 25,985 | $22.50 | +26% | +8% | Feb 11 | SEC |
| Feb 13 | DMLPDorchester Minerals, L.P. | Dorchester Minerals Operating…10b5-1Entity Under Common Control | $504.75K | 20,000 | $25.24 | +10% | +80% | Feb 11 | SEC |
| Feb 13 | ZBIOZenas BioPharma, Inc. | Allen Patricia LDirector | $499.75K | 19,860 | $25.16 | +13% | — | Feb 12 | SEC |
| Feb 13 | SRZNSurrozen, Inc. | TCG Crossover Fund II, L.P. +3indirect10% Owner | $444.93K | 18,856 | $23.60 | +34% | +3% | Feb 11 | SEC |
| Feb 13 | NRXNeuraxis, INC | Hannasch Brian10% Owner | $382.80K | 80,000 | $4.79 | — | +7% | Feb 11 | SEC |
| Feb 13 | ONEWOneWater Marine Inc. | Singleton Asset Management, L…indirectMember of 10% Ownership Group | $307.50K | 24,353 | $12.63 | -16% | +3% | Feb 11 | SEC |
| Feb 13 | QDELQuidelOrtho Corp | Blaser Brian J.indirectPresident and CEO | $248.64K | 10,540 | $23.59 | -39% | +36% | Feb 13 | SEC |
| Feb 13 | QDELQuidelOrtho Corp | Strobeck MatthewDirector | $239.60K | 10,000 | $23.96 | -40% | +56% | Feb 13 | SEC |
| Feb 13 | SCSCScansource, Inc. | Mathis Charles AlexanderDirector | $211.23K | 6,000 | $35.20 | +62% | +34% | Feb 11 | SEC |
| Feb 13 | PFSIPennyMac Financial Services… | Kinsella PatrickDirector | $200.59K | 2,250 | $89.15 | -24% | +7% | Feb 12 | SEC |
| Feb 13 | CHRWC. H. Robinson Worldwide, Inc. | Bozeman David PPresident & CEO, Director | $199.78K | 1,223 | $163.35 | -18% | +1% | Feb 12 | SEC |
| Feb 13 | CLFCleveland-Cliffs Inc. | Camara EdilsonDirector | $199.56K | 19,700 | $10.13 | +27% | +88% | Feb 13 | SEC |
| Feb 13 | CINFCincinnati Financial Corp | Debbink Dirk JindirectDirector | $162.58K | 1,000 | $162.58 | +17% | +2% | Feb 11 | SEC |
| Feb 13 | COSMCosmos Health Inc. | Siokas GrigoriosChief Executive Officer, Director… | $143.76K | 388,532 | $0.37 | -11% | +5% | Feb 12 | SEC |
| Feb 13 | AXRAmrep Corp. | Dahl James H +110% Owner | $103.29K | 4,358 | $23.70 | -10% | +1% | Feb 12 | SEC |
| Feb 13 | CHRWC. H. Robinson Worldwide, Inc. | Rajan ArunChief Strat & Innov Officer | $101.10K | 605 | $167.11 | -20% | +0% | Feb 12 | SEC |
| Feb 13 | CHRWC. H. Robinson Worldwide, Inc. | Lee Damon J.Chief Financial Officer | $100.76K | 620 | $162.52 | -18% | +2% | Feb 12 | SEC |
| Feb 13 | CMTVCommunity Bancorp | Marvin EmmaDirector | $100.75K | 3,100 | $32.50 | +41% | +47% | Feb 13 | SEC |
| Feb 13 | CHRWC. H. Robinson Worldwide, Inc. | Castagnetto Michael D.Pres, NAST | $100K | 594 | $168.24 | -20% | +2% | Feb 12 | SEC |
| Feb 13 | CHUCCharlie's Holdings, Inc. | King Michael DDirector | $100K | 500,000 | $0.20 | -49% | +8% | Feb 13 | SEC |
| Feb 13 | TENBTenable Holdings, Inc. | Vicks Raymond Jr.Director | $99.77K | 4,500 | $22.17 | +114% | +38% | Feb 12 | SEC |
| Feb 13 | LUCKLucky Strike Entertainment Co… | Harinstein JasonDirector | $98.02K | 13,000 | $7.54 | -41% | new | Feb 12 | SEC |
| Feb 13 | PNFPPinnacle Financial Partners… | Gregory Andrew J. Jr.Chief Financial Officer | $94.52K | 1,000 | $94.52 | +10% | +2% | Feb 12 | SEC |
| Feb 13 | ONCYOncolytics Biotech Inc | Seizinger Bernd R.Director | $83.80K | 100,000 | $0.84 | -50% | +21% | Feb 11 | SEC |
| Feb 13 | TSITcw Strategic Income Fund Inc | McMillan PeterDirector | $81.91K | 17,390 | $4.71 | -7.2% | +9% | Feb 13 | SEC |
| Feb 13 | QDELQuidelOrtho Corp | Busky Joseph M.indirectChief Financial Officer | $79.73K | 3,370 | $23.66 | -39% | +49% | Feb 13 | SEC |
| Feb 13 | BWFGBankwell Financial Group, Inc. | Seidman Lawrence BindirectDirector | $76.98K | 1,600 | $48.11 | +52% | +8% | Feb 12 | SEC |
| Feb 13 | DLHCDLH Holdings Corp. | Mink Brook Asset Management L…indirect10% Owner | $76.43K | 13,896 | $5.50 | -33% | +1% | Feb 12 | SEC |
| Feb 13 | RBBNRibbon Communications Inc. | McClelland Bruce WilliamPresident & CEO, Director | $74.34K | 37,000 | $2.01 | -23% | +2% | Feb 10 | SEC |
| Feb 13 | WTWWillis Towers Watson PLC | Hammond Michael P.Director | $67.21K | 241 | $278.86 | +21% | +11% | Feb 12 | SEC |
| Feb 13 | SNESSenesTech, Inc. | Glenbrook Capital Managementindirect10% Owner | $56.61K | 31,346 | $1.81 | -33% | +5% | Feb 11 | SEC |
| Feb 13 | CHUCCharlie's Holdings, Inc. | Stump RyanChief Operating Officer | $50K | 250,000 | $0.20 | -49% | +12% | Feb 13 | SEC |
| Feb 13 | CHUCCharlie's Holdings, Inc. | Sicignano Henry IIIPresident | $50K | 250,000 | $0.20 | -49% | +3% | Feb 13 | SEC |
| Feb 13 | CHUCCharlie's Holdings, Inc. | Carmines EdwardDirector | $50K | 250,000 | $0.20 | -49% | +13% | Feb 13 | SEC |
| Feb 13 | AVBCAvidia Bancorp, Inc. | Cozzone Robert DindirectPresident & CEO, Director | $49.99K | 2,582 | $19.36 | +19% | +4% | Feb 11 | SEC |
| Feb 13 | CXHMfs Investment Grade Municipa… | Dakos Andrew +210% Owner | $32.31K | 3,989 | $8.10 | — | +31% | Feb 11 | SEC |
| Feb 13 | ONCYOncolytics Biotech Inc | Andrews Patricia SDirector | $30.44K | 35,400 | $0.86 | -51% | +83% | Feb 12 | SEC |
| Feb 13 | ONCYOncolytics Biotech Inc | Kelly JaredChief Executive Officer, Director | $29.48K | 35,100 | $0.84 | -50% | +48% | Feb 11 | SEC |
| Feb 13 | PBHCPathfinder Bancorp, Inc. | Gagas Adam C.indirectDirector | $26.89K | 1,956 | $13.75 | +22% | +12% | Feb 12 | SEC |
| Feb 13 | ONCYOncolytics Biotech Inc | Aromando AndrewChief Business Officer | $25.46K | 29,600 | $0.86 | -51% | +116% | Feb 11 | SEC |
| Feb 13 | ONCYOncolytics Biotech Inc | Pisano WayneDirector | $25.20K | 30,000 | $0.84 | -50% | +6% | Feb 12 | SEC |
| Feb 13 | ONCYOncolytics Biotech Inc | Brown Deborah MargaretDirector | $21.25K | 25,000 | $0.85 | -51% | +30% | Feb 12 | SEC |
| Feb 13 | CHUCCharlie's Holdings, Inc. | Montesano Matthew PChief Financial Officer | $20K | 100,000 | $0.20 | -49% | +4% | Feb 13 | SEC |
| Feb 13 | NAIFXNomura Alternative Income Fund | Rosa Katherine QuickTrustee | $13.75K | 1,404 | $9.79 | -1.7% | +27% | Feb 12 | SEC |
| Feb 13 | ONCYOncolytics Biotech Inc | Look KirkChief Financial Officer | $10.08K | 12,000 | $0.84 | -50% | +4% | Feb 12 | SEC |
| Feb 13 | ONCYOncolytics Biotech Inc | Heineman Thomas CharlesChief Medical Officer | $10.07K | 12,132 | $0.83 | -49% | +4% | Feb 12 | SEC |
Get insider buys on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on Telegram